CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court

New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving alleged cheating by a former Assistant Drugs Controller of Himachal Pradesh, Nishant Sareen, among others.

The case came to light following allegations that the official, despite being directed by the Supreme Court to surrender to the trial court within four weeks, continued to attend office. This act of defiance raised questions about the support he might have received from the investigating agency handling the case.

The High Court’s decision was influenced by the petitioner’s counsel highlighting potential obstructions in the investigation, including the frequent reassignment of Investigating Officers, especially before court hearings. The court observed these actions as deliberate attempts to impede the judicial process.

Acknowledging the gravity of the accusations, which include complicity of police officers, the High Court deemed it necessary for an independent body like the CBI to conduct a fair and unbiased investigation.

“Taking into consideration the entire facts of the case and very serious allegations made against all the respondents including police officers, it is a fit case where the investigation has to be handed over to an independent agency like CBI for the purpose of fair and unbiased investigation,” the court noted in the order.

This order marks a pivotal move towards ensuring the integrity of the judicial system and upholding the rule of law. The CBI’s involvement is expected to bring transparency to the proceedings and address the serious allegations leveled against the respondents.

Related Posts

  • Pharma
  • February 5, 2025
  • 118 views
Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

A leading pharmaceutical powerhouse renowned for innovative skincare solutions has unveiled its latest breakthrough in tackling facial hyperpigmentation. The groundbreaking serum, featuring a first-of-its-kind dual liposomal technology in India, promises…

  • Pharma
  • February 5, 2025
  • 127 views
Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners (RMPs) and representatives of pharmaceutical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

As Always Ahead of Game in healthcare, Doc was first to vote too

As Always Ahead of Game in healthcare, Doc was first to vote too

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds